Annual EPS
-$13.43
+$3.37+20.06%
31 December 2023
Summary:
Oncternal Therapeutics annual earnings per share is currently -$13.43, with the most recent change of +$3.37 (+20.06%) on 31 December 2023. During the last 3 years, it has risen by +$3.57 (+21.00%). ONCT annual EPS is now -102.46% below its all-time high of $546.00, reached on 31 December 2010.ONCT EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$2.86
+$0.03+1.04%
30 September 2024
Summary:
Oncternal Therapeutics quarterly earnings per share is currently -$2.86, with the most recent change of +$0.03 (+1.04%) on 30 September 2024. Over the past year, it has increased by +$0.49 (+14.63%). ONCT quarterly EPS is now -100.17% below its all-time high of $1708.00, reached on 31 March 2010.ONCT Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$11.69
+$0.49+4.02%
30 September 2024
Summary:
Oncternal Therapeutics TTM earnings per share is currently -$11.69, with the most recent change of +$0.49 (+4.02%) on 30 September 2024. Over the past year, it has increased by +$2.64 (+18.42%). ONCT TTM EPS is now -102.20% below its all-time high of $532.00, reached on 31 December 2010.ONCT TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.1% | +14.6% | +18.4% |
| 3 y3 years | +21.0% | +24.7% | -4.4% |
| 5 y5 years | +94.2% | +55.3% | +91.5% |
ONCT EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.9% | +21.0% | -1.1% | +37.8% | -4.4% | +30.4% |
| 5 y | 5 years | -4.9% | +94.2% | -184.1% | +57.9% | -4.4% | +91.5% |
| alltime | all time | -102.5% | +99.9% | -100.2% | +100.0% | -102.2% | +99.9% |
Oncternal Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.86(-1.0%) | -$11.69(-4.0%) |
| June 2024 | - | -$2.89(+2.1%) | -$12.18(-1.3%) |
| Mar 2024 | - | -$2.83(-9.0%) | -$12.34(-8.2%) |
| Dec 2023 | -$13.43(-20.1%) | -$3.11(-7.2%) | -$13.44(-6.2%) |
| Sept 2023 | - | -$3.35(+9.8%) | -$14.33(-5.6%) |
| June 2023 | - | -$3.05(-22.4%) | -$15.18(-9.3%) |
| Mar 2023 | - | -$3.93(-1.8%) | -$16.73(-0.4%) |
| Dec 2022 | -$16.80(+31.3%) | -$4.00(-4.8%) | -$16.80(+5.0%) |
| Sept 2022 | - | -$4.20(-8.7%) | -$16.00(+2.6%) |
| June 2022 | - | -$4.60(+15.0%) | -$15.60(+9.9%) |
| Mar 2022 | - | -$4.00(+25.0%) | -$14.20(+12.7%) |
| Dec 2021 | -$12.80(-24.7%) | -$3.20(-15.8%) | -$12.60(+12.5%) |
| Sept 2021 | - | -$3.80(+18.8%) | -$11.20(-5.1%) |
| June 2021 | - | -$3.20(+33.3%) | -$11.80(-23.4%) |
| Mar 2021 | - | -$2.40(+33.3%) | -$15.40(-19.8%) |
| Dec 2020 | -$17.00(-74.3%) | -$1.80(-59.1%) | -$19.20(+37.1%) |
| Sept 2020 | - | -$4.40(-35.3%) | -$14.00(-12.5%) |
| June 2020 | - | -$6.80(+9.7%) | -$16.00(-79.2%) |
| Mar 2020 | - | -$6.20(-282.4%) | -$76.80(-26.3%) |
| Dec 2019 | -$66.20(-71.3%) | $3.40(-153.1%) | -$104.20(-24.7%) |
| Sept 2019 | - | -$6.40(-90.5%) | -$138.40(-25.8%) |
| June 2019 | - | -$67.60(+101.2%) | -$186.60(+4.1%) |
| Mar 2019 | - | -$33.60(+9.1%) | -$179.20(-22.9%) |
| Dec 2018 | -$231.00(-5.7%) | -$30.80(-43.6%) | -$232.40(-11.2%) |
| Sept 2018 | - | -$54.60(-9.3%) | -$261.80(-7.0%) |
| June 2018 | - | -$60.20(-30.6%) | -$281.40(+1.5%) |
| Mar 2018 | - | -$86.80(+44.2%) | -$277.20(+13.1%) |
| Dec 2017 | -$245.00(+43.4%) | -$60.20(-18.9%) | -$245.00(-0.6%) |
| Sept 2017 | - | -$74.20(+32.5%) | -$246.40(+2.3%) |
| June 2017 | - | -$56.00(+2.6%) | -$240.80(-1.7%) |
| Mar 2017 | - | -$54.60(-11.4%) | -$245.00(+44.6%) |
| Dec 2016 | -$170.80(-17.0%) | -$61.60(-10.2%) | -$169.40(+3.4%) |
| Sept 2016 | - | -$68.60(+14.0%) | -$163.80(+8.3%) |
| June 2016 | - | -$60.20(-386.7%) | -$151.20(-73.3%) |
| Mar 2016 | - | $21.00(-137.5%) | -$567.00(-8.0%) |
| Dec 2015 | -$205.80(-69.5%) | -$56.00(0.0%) | -$616.00(-17.0%) |
| Sept 2015 | - | -$56.00(-88.2%) | -$742.00(-3.6%) |
| June 2015 | - | -$476.00(+1600.0%) | -$770.00(+52.8%) |
| Mar 2015 | - | -$28.00(-84.6%) | -$504.00(-25.0%) |
| Dec 2014 | -$674.80(-28.1%) | -$182.00(+116.7%) | -$672.00(+2.1%) |
| Sept 2014 | - | -$84.00(-60.0%) | -$658.00(-14.5%) |
| June 2014 | - | -$210.00(+7.1%) | -$770.00(-8.3%) |
| Mar 2014 | - | -$196.00(+16.7%) | -$840.00(-9.1%) |
| Dec 2013 | -$938.00 | -$168.00(-14.3%) | -$924.00(-7.0%) |
| Sept 2013 | - | -$196.00(-30.0%) | -$994.00(+44.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$280.00(0.0%) | -$686.00(+6.5%) |
| Mar 2013 | - | -$280.00(+17.6%) | -$644.00(+4.5%) |
| Dec 2012 | -$602.00(-25.9%) | -$238.00(-312.5%) | -$616.00(0.0%) |
| Sept 2012 | - | $112.00(-147.1%) | -$616.00(-34.3%) |
| June 2012 | - | -$238.00(-5.6%) | -$938.00(-5.6%) |
| Mar 2012 | - | -$252.00(+5.9%) | -$994.00(+22.4%) |
| Dec 2011 | -$812.00(-248.7%) | -$238.00(+13.3%) | -$812.00(-10.8%) |
| Sept 2011 | - | -$210.00(-28.6%) | -$910.00(-12.2%) |
| June 2011 | - | -$294.00(+320.0%) | -$1036.00(-16.9%) |
| Mar 2011 | - | -$70.00(-79.2%) | -$1246.00(-334.2%) |
| Dec 2010 | $546.00(-130.7%) | -$336.00(0.0%) | $532.00(+18.8%) |
| Sept 2010 | - | -$336.00(-33.3%) | $448.00(+52.4%) |
| June 2010 | - | -$504.00(-129.5%) | $294.00(-19.2%) |
| Mar 2010 | - | $1708.00(-506.7%) | $364.00(-120.5%) |
| Dec 2009 | -$1778.00(-11.2%) | -$420.00(-14.3%) | -$1778.00(-5.9%) |
| Sept 2009 | - | -$490.00(+12.9%) | -$1890.00(+1.5%) |
| June 2009 | - | -$434.00(0.0%) | -$1862.00(-4.3%) |
| Mar 2009 | - | -$434.00(-18.4%) | -$1946.00(-2.8%) |
| Dec 2008 | -$2002.00(+23.3%) | -$532.00(+15.2%) | -$2002.00(+0.7%) |
| Sept 2008 | - | -$462.00(-10.8%) | -$1988.00(+2.9%) |
| June 2008 | - | -$518.00(+5.7%) | -$1932.00(+8.7%) |
| Mar 2008 | - | -$490.00(-5.4%) | -$1778.00(+10.4%) |
| Dec 2007 | -$1624.00(+1.8%) | -$518.00(+27.6%) | -$1610.00(+23.7%) |
| Sept 2007 | - | -$406.00(+11.5%) | -$1302.00(-6.1%) |
| June 2007 | - | -$364.00(+13.0%) | -$1386.00(-5.7%) |
| Mar 2007 | - | -$322.00(+53.3%) | -$1470.00(-7.9%) |
| Dec 2006 | -$1596.00(-19.7%) | -$210.00(-57.1%) | -$1596.00(-7.3%) |
| Sept 2006 | - | -$490.00(+9.4%) | -$1722.00(-3.9%) |
| June 2006 | - | -$448.00(0.0%) | -$1792.00(-6.6%) |
| Mar 2006 | - | -$448.00(+33.3%) | -$1918.00(-3.5%) |
| Dec 2005 | -$1988.00(+52.7%) | -$336.00(-40.0%) | -$1988.00(-4.1%) |
| Sept 2005 | - | -$560.00(-2.4%) | -$2072.00(+14.7%) |
| June 2005 | - | -$574.00(+10.8%) | -$1806.00(+21.7%) |
| Mar 2005 | - | -$518.00(+23.3%) | -$1484.00(+11.6%) |
| Dec 2004 | -$1302.00(-92.5%) | -$420.00(+42.9%) | -$1330.00(-37.9%) |
| Sept 2004 | - | -$294.00(+16.7%) | -$2142.00(-87.7%) |
| June 2004 | - | -$252.00(-30.8%) | -$17.36 K(-0.3%) |
| Mar 2004 | - | -$364.00(-70.5%) | -$17.42 K(-1.6%) |
| Dec 2003 | -$17.28 K(+348.7%) | -$1232.00(-92.1%) | -$17.70 K(+7.5%) |
| Sept 2003 | - | -$15.51 K(+4936.4%) | -$16.46 K(+1629.4%) |
| June 2003 | - | -$308.00(-52.2%) | -$952.00(+47.8%) |
| Mar 2003 | - | -$644.00 | -$644.00 |
| Dec 2002 | -$3850.00(+139.1%) | - | - |
| Dec 2001 | -$1610.00(-64.7%) | - | - |
| Dec 2000 | -$4564.00(+2863.6%) | - | - |
| Dec 1999 | -$154.00 | - | - |
FAQ
- What is Oncternal Therapeutics annual earnings per share?
- What is the all time high annual EPS for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual EPS year-on-year change?
- What is Oncternal Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly EPS year-on-year change?
- What is Oncternal Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Oncternal Therapeutics?
- What is Oncternal Therapeutics TTM EPS year-on-year change?
What is Oncternal Therapeutics annual earnings per share?
The current annual EPS of ONCT is -$13.43
What is the all time high annual EPS for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual earnings per share is $546.00
What is Oncternal Therapeutics annual EPS year-on-year change?
Over the past year, ONCT annual earnings per share has changed by +$3.37 (+20.06%)
What is Oncternal Therapeutics quarterly earnings per share?
The current quarterly EPS of ONCT is -$2.86
What is the all time high quarterly EPS for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly earnings per share is $1708.00
What is Oncternal Therapeutics quarterly EPS year-on-year change?
Over the past year, ONCT quarterly earnings per share has changed by +$0.49 (+14.63%)
What is Oncternal Therapeutics TTM earnings per share?
The current TTM EPS of ONCT is -$11.69
What is the all time high TTM EPS for Oncternal Therapeutics?
Oncternal Therapeutics all-time high TTM earnings per share is $532.00
What is Oncternal Therapeutics TTM EPS year-on-year change?
Over the past year, ONCT TTM earnings per share has changed by +$2.64 (+18.42%)